Salomon Rivera

255 Fieldston Terrace Apt 6 K, Bronx, NY, 10471, US
Doctor Highlights
-
New Patients Welcome
-
Patient-Centered Care
About Salomon Rivera
Salomon Rivera is a highly respected medical marijuana specialist based in Bronx, NY, with a reputation for excellence in patient care and groundbreaking contributions to the field of cannabis therapeutics. With a robust background in medical training and specialized expertise in cannabis treatments, Salomon Rivera stands as a trusted authority at the forefront of integrating medicine and cannabis.
Taking a holistic approach to healthcare, Salomon Rivera prioritizes understanding each patient's unique medical history, conditions, and goals to create personalized treatment plans that harness the potential benefits of medical cannabis. Their commitment to staying current with cutting-edge research ensures that patients receive the most effective and evidence-based care available.
Empowering patients through education is a cornerstone of Salomon Rivera's practice. By providing in-depth information on the science behind medical cannabis, potential advantages, risks, and optimal usage guidelines, they enable patients to make informed decisions about their health with confidence.
Salomon Rivera's collaborative approach to healthcare fosters strong patient partnerships built on trust and respect, encouraging open communication and active participation in the treatment journey. Patients consistently praise Salomon Rivera's compassionate and empathetic care, creating a welcoming environment where health concerns can be openly discussed.
Beyond individual patient care, Salomon Rivera is dedicated to advocacy and community engagement, working to promote awareness and destigmatization of medical cannabis. Their efforts contribute to the broader acceptance and understanding of cannabis as a valuable treatment option.
With a tone of professionalism, approachability, and trustworthiness, Salomon Rivera's brand description reflects their unwavering commitment to patient well-being, dedication to advancing medical cannabis treatment, and profound impact on the field of cannabis therapeutics.
Navigating New York’s Cannabis Laws
To qualify for medical cannabis in New York, patients must have a diagnosed condition like chronic pain, PTSD, or epilepsy. A healthcare provider registered with the state must issue a certification outlining the patient's need for cannabis, including dosage and form. Patients must then register with the New York Medical Marijuana Program to receive an official identification card. This system ensures that cannabis is used responsibly and exclusively for medical purposes.
Recreational Cannabis: Legal Overview
New York legalized recreational cannabis in 2021 under the Marijuana Regulation and Taxation Act (MRTA). Adults 21 and older can possess up to three ounces of cannabis. However, home cultivation remains restricted for recreational users. The law aims to create a regulated market while prioritizing social equity. Patients in the medical program continue to enjoy certain privileges, such as higher possession limits and access to a wider range of products.
Purchasing Limits and Possession Guidelines
Medical cannabis patients may purchase up to a 60-day supply as recommended by their certifying practitioner. Recreational users are limited to three ounces of cannabis flower or 24 grams of concentrate. Possession exceeding these amounts can result in penalties. These restrictions help maintain compliance with state laws while preventing misuse.
Cannabis Use in Public Spaces
While recreational and medical cannabis are legal, public consumption is generally prohibited. Designated consumption lounges are expected to open in the future, offering safe spaces for cannabis use. Until then, users should consume cannabis on private property. Non-compliance with public use laws can lead to fines.
Future Legal Updates
New York’s cannabis laws continue to evolve, with future updates expected to address home cultivation for recreational users and the expansion of consumption lounges. Keeping up with these changes ensures that patients and users remain compliant while benefiting from the program's growth.
